Longer cumulative use of medication to treat attention-deficit/hyperactivity disorder (ADHD) is associated with a small, but statistically significant, increased risk ...
The American Heart Association (AHA) has unveiled a new heart disease risk calculator that aims to estimate an individual's long-term ...
PHILADELPHIA — Giving the SGLT-2 inhibitor dapagliflozin (Farxiga) to patients with acute myocardial infarction (MI) and impaired left ventricular systolic ...
Lawrence Faucette, the 58-year-old man with terminal heart disease who received the world's second genetically modified pig heart transplant, passed ...
AMSTERDAM — Adults with type 2 diabetes who were on a sodium-glucose cotransporter 2 (SGLT2) inhibitor at the time of ...
Once-daily treatment with the selective aldosterone synthase inhibitor lorundrostat (Mineralys Therapeutics) safely and significantly reduced blood pressure in adults with ...
The European Society of Cardiology has released new guidelines for cardiomyopathies, their first major comprehensive international guidelines to address diagnosis ...
Survivors of out-of-hospital cardiac arrest (OHCA) without ST-segment elevation who were transported to the nearest hospital emergency department had similar ...
Abiomed has voluntarily recalled the labeling for one model of its Impella circulatory assist pumps because it doesn't "appropriately address" ...
Mumbai: Lupin Digital Health (LDH) announced the launch of its newest offering, LyfeTM Digital Heart Failure Clinic in India. The ...
© Pharma News Hubb All rights reserved.
Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.